BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 30191480)

  • 21. Studies of SARM1 uncover similarities between immune and neuronal responses to danger.
    Dalod M
    Sci STKE; 2007 Dec; 2007(417):pe73. PubMed ID: 18089857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The SARM1 TIR NADase: Mechanistic Similarities to Bacterial Phage Defense and Toxin-Antitoxin Systems.
    DiAntonio A; Milbrandt J; Figley MD
    Front Immunol; 2021; 12():752898. PubMed ID: 34630431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wallerian Degeneration Is Executed by an NMN-SARM1-Dependent Late Ca(2+) Influx but Only Modestly Influenced by Mitochondria.
    Loreto A; Di Stefano M; Gering M; Conforti L
    Cell Rep; 2015 Dec; 13(11):2539-2552. PubMed ID: 26686637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARM1 promotes neuroinflammation and inhibits neural regeneration after spinal cord injury through NF-κB signaling.
    Liu H; Zhang J; Xu X; Lu S; Yang D; Xie C; Jia M; Zhang W; Jin L; Wang X; Shen X; Li F; Wang W; Bao X; Li S; Zhu M; Wang W; Wang Y; Huang Z; Teng H
    Theranostics; 2021; 11(9):4187-4206. PubMed ID: 33754056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The SARM1 TIR domain produces glycocyclic ADPR molecules as minor products.
    Garb J; Amitai G; Lu A; Ofir G; Brandis A; Mehlman T; Kranzusch PJ; Sorek R
    PLoS One; 2024; 19(4):e0302251. PubMed ID: 38635746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Traumatic axonopathy in spinal tracts after impact acceleration head injury: Ultrastructural observations and evidence of SARM1-dependent axonal degeneration.
    Alexandris AS; Lee Y; Lehar M; Alam Z; Samineni P; Tripathi SJ; Ryu J; Koliatsos VE
    Exp Neurol; 2023 Jan; 359():114252. PubMed ID: 36244414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TIR Axons Apart: Unpredicted NADase Controls Axonal Degeneration.
    Goldner R; Yaron A
    Neuron; 2017 Mar; 93(6):1239-1241. PubMed ID: 28334598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sarm1 knockout protects against early but not late axonal degeneration in experimental allergic encephalomyelitis.
    Viar K; Njoku D; Secor McVoy J; Oh U
    PLoS One; 2020; 15(6):e0235110. PubMed ID: 32584865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons.
    Sasaki Y; Engber TM; Hughes RO; Figley MD; Wu T; Bosanac T; Devraj R; Milbrandt J; Krauss R; DiAntonio A
    Exp Neurol; 2020 Jul; 329():113252. PubMed ID: 32087251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic diversity of axon degenerative mechanisms in models of Parkinson's disease.
    Peters OM; Weiss A; Metterville J; Song L; Logan R; Smith GA; Schwarzschild MA; Mueller C; Brown RH; Freeman M
    Neurobiol Dis; 2021 Jul; 155():105368. PubMed ID: 33892050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARM1 signaling mechanisms in the injured nervous system.
    Sambashivan S; Freeman MR
    Curr Opin Neurobiol; 2021 Aug; 69():247-255. PubMed ID: 34175654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mitochondrial protein NLRX1 controls the balance between extrinsic and intrinsic apoptosis.
    Soares F; Tattoli I; Rahman MA; Robertson SJ; Belcheva A; Liu D; Streutker C; Winer S; Winer DA; Martin A; Philpott DJ; Arnoult D; Girardin SE
    J Biol Chem; 2014 Jul; 289(28):19317-30. PubMed ID: 24867956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitochondrial dysfunction induces Sarm1-dependent cell death in sensory neurons.
    Summers DW; DiAntonio A; Milbrandt J
    J Neurosci; 2014 Jul; 34(28):9338-50. PubMed ID: 25009267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. dSarm/Sarm1 is required for activation of an injury-induced axon death pathway.
    Osterloh JM; Yang J; Rooney TM; Fox AN; Adalbert R; Powell EH; Sheehan AE; Avery MA; Hackett R; Logan MA; MacDonald JM; Ziegenfuss JS; Milde S; Hou YJ; Nathan C; Ding A; Brown RH; Conforti L; Coleman M; Tessier-Lavigne M; Züchner S; Freeman MR
    Science; 2012 Jul; 337(6093):481-4. PubMed ID: 22678360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sarm1 loss reduces axonal damage and improves cognitive outcome after repetitive mild closed head injury.
    Maynard ME; Redell JB; Zhao J; Hood KN; Vita SM; Kobori N; Dash PK
    Exp Neurol; 2020 May; 327():113207. PubMed ID: 31962129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Traumatic Axonal Injury in the Optic Nerve: The Selective Role of SARM1 in the Evolution of Distal Axonopathy.
    Alexandris AS; Lee Y; Lehar M; Alam Z; McKenney J; Perdomo D; Ryu J; Welsbie D; Zack DJ; Koliatsos VE
    J Neurotrauma; 2023 Aug; 40(15-16):1743-1761. PubMed ID: 36680758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Context-Specific Stress Causes Compartmentalized SARM1 Activation and Local Degeneration in Cortical Neurons.
    Hinz FI; Villegas CLM; Roberts JT; Yao H; Gaddam S; Delwig A; Green SA; Fredrickson C; Adrian M; Asuncion RR; Cheung TK; Hayne M; Hackos DH; Rose CM; Richmond D; Hoogenraad CC
    J Neurosci; 2024 Jun; 44(24):. PubMed ID: 38692735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation.
    Pan ZG; An XS
    Biochem Biophys Res Commun; 2018 Apr; 498(3):416-423. PubMed ID: 29454967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of SARM1 as a Potential Therapeutic Target for Wallerian-type Diseases.
    Loring HS; Thompson PR
    Cell Chem Biol; 2020 Jan; 27(1):1-13. PubMed ID: 31761689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The curious case of SARM1: Dr. Jekyll and Mr. Hyde in cell death and immunity?
    Sarkar A; Kumari N; Mukherjee P
    FEBS J; 2023 Jan; 290(2):340-358. PubMed ID: 34710262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.